Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Carasent AB ( (SE:CARA) ) just unveiled an update.
Carasent AB’s annual general meeting approved key governance and capital decisions, including maintaining a five-member board, re-electing all sitting directors with Tomas Meerits as chair, and confirming KPMG as auditor. The meeting also endorsed the board’s remuneration framework for directors and committee work while deciding not to distribute a dividend for the 2025 financial year.
Shareholders approved a new long-term incentive program of up to 350,000 warrants for senior executives and key staff, aligning management rewards with future share price performance over a vesting period to 2029. The AGM further authorized adjustments to the articles of association and capital structure, including a bonus issue, cancellation of 2,000,000 treasury shares, and mandates for new share issues and buybacks of up to 10 percent of outstanding shares to provide strategic flexibility and support potential acquisitions.
More about Carasent AB
Carasent AB is a Swedish publicly listed company that operates in the technology and digital services sector for healthcare and related professional markets. The company focuses on providing software-based solutions and services that support operational efficiency and digitalization for its customers, primarily in the Nordic region and broader European market.
Average Trading Volume: 154,225
Technical Sentiment Signal: Hold
Current Market Cap: SEK1.57B
See more insights into CARA stock on TipRanks’ Stock Analysis page.